vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
Laird Superfood, Inc. is the larger business by last-quarter revenue ($13.3M vs $13.2M, roughly 1.0× TriSalus Life Sciences, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -73.9%, a 60.7% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 15.0%). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 16.1%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
LSF vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $13.2M |
| Net Profit | $-1.8M | $-9.8M |
| Gross Margin | 34.1% | 86.7% |
| Operating Margin | -13.5% | -24.8% |
| Net Margin | -13.2% | -73.9% |
| Revenue YoY | 15.0% | 59.8% |
| Net Profit YoY | -341.4% | 3.5% |
| EPS (diluted) | — | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $13.2M | ||
| Q3 25 | $12.9M | $11.6M | ||
| Q2 25 | $12.0M | $11.2M | ||
| Q1 25 | $11.7M | $9.2M | ||
| Q4 24 | $11.6M | $8.3M | ||
| Q3 24 | $11.8M | $7.3M | ||
| Q2 24 | $10.0M | $7.4M | ||
| Q1 24 | $9.9M | $6.5M |
| Q4 25 | $-1.8M | $-9.8M | ||
| Q3 25 | $-975.1K | $-10.8M | ||
| Q2 25 | $-362.2K | $-8.3M | ||
| Q1 25 | $-156.2K | $-10.4M | ||
| Q4 24 | $-398.4K | $-10.1M | ||
| Q3 24 | $-166.1K | $-2.4M | ||
| Q2 24 | $-239.1K | $-4.3M | ||
| Q1 24 | $-1.0M | $-13.2M |
| Q4 25 | 34.1% | 86.7% | ||
| Q3 25 | 36.5% | 83.5% | ||
| Q2 25 | 39.9% | 83.9% | ||
| Q1 25 | 41.9% | 83.7% | ||
| Q4 24 | 38.6% | 85.3% | ||
| Q3 24 | 43.0% | 86.3% | ||
| Q2 24 | 41.8% | 87.6% | ||
| Q1 24 | 40.0% | 85.0% |
| Q4 25 | -13.5% | -24.8% | ||
| Q3 25 | -7.7% | -77.9% | ||
| Q2 25 | -3.3% | -65.4% | ||
| Q1 25 | -1.9% | -79.9% | ||
| Q4 24 | -4.1% | -91.8% | ||
| Q3 24 | -2.3% | -118.9% | ||
| Q2 24 | -3.4% | -111.0% | ||
| Q1 24 | -11.0% | -180.8% |
| Q4 25 | -13.2% | -73.9% | ||
| Q3 25 | -7.6% | -93.5% | ||
| Q2 25 | -3.0% | -73.9% | ||
| Q1 25 | -1.3% | -113.2% | ||
| Q4 24 | -3.4% | -122.4% | ||
| Q3 24 | -1.4% | -32.6% | ||
| Q2 24 | -2.4% | -58.8% | ||
| Q1 24 | -10.3% | -204.5% |
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.96 | ||
| Q2 25 | — | $-0.27 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $-0.21 | ||
| Q1 24 | — | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $-33.9M |
| Total Assets | $19.2M | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $20.4M | ||
| Q3 25 | $5.1M | $22.7M | ||
| Q2 25 | $3.9M | $26.5M | ||
| Q1 25 | $7.0M | $13.0M | ||
| Q4 24 | $8.3M | $8.5M | ||
| Q3 24 | $7.9M | $11.3M | ||
| Q2 24 | $7.6M | $16.5M | ||
| Q1 24 | $7.1M | $4.0M |
| Q4 25 | $11.5M | $-33.9M | ||
| Q3 25 | $12.8M | $-26.7M | ||
| Q2 25 | $13.4M | $-19.4M | ||
| Q1 25 | $13.3M | $-34.4M | ||
| Q4 24 | $13.2M | $-25.9M | ||
| Q3 24 | $13.1M | $-20.4M | ||
| Q2 24 | $12.6M | $-25.3M | ||
| Q1 24 | $12.7M | $-36.0M |
| Q4 25 | $19.2M | $35.3M | ||
| Q3 25 | $18.9M | $36.5M | ||
| Q2 25 | $20.4M | $41.3M | ||
| Q1 25 | $21.5M | $28.6M | ||
| Q4 24 | $19.3M | $24.0M | ||
| Q3 24 | $18.8M | $27.5M | ||
| Q2 24 | $18.0M | $32.4M | ||
| Q1 24 | $17.6M | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-2.5M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $-2.8M | $-7.3M | ||
| Q1 25 | $-1.3M | $-4.5M | ||
| Q4 24 | $339.2K | $-5.7M | ||
| Q3 24 | $305.8K | $-10.8M | ||
| Q2 24 | $642.7K | $-13.4M | ||
| Q1 24 | $-422.3K | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
TLSI
Segment breakdown not available.
